Recombinant bovine basic fibroblast growth factor (Changchun ChangSheng Gene)

重组牛碱性成纤维细胞生长因子(长春长生基因药业)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant bovine basic fibroblast growth factor (Changchun ChangSheng Gene)
Drug Alias Name见林
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptors modulators
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsWounds and Injuries
Approved Indications in ChinaWounds and Injuries
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A